| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/16/2008 | CN100381466C Human pifl gene, its coding protein and use thereof |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381461C Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity |
| 04/16/2008 | CN100381460C HER-2 analogue antigen epitope and peptide containing said epitope |
| 04/16/2008 | CN100381459C Adriamycin derivative and its preparing method and use |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381169C Composite collagen eye drops |
| 04/16/2008 | CN100381168C Use of glucoprotein for pharmaceuticals |
| 04/16/2008 | CN100381167C Medicine for treating neurasthenia |
| 04/16/2008 | CN100381166C Suppository for treating chronic cervicitis |
| 04/16/2008 | CN100381165C Medication for improving sleep |
| 04/16/2008 | CN100381164C Medicine for treating radiation diseases |
| 04/15/2008 | US7358386 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 04/15/2008 | US7358379 Steroid conjugates, preparation thereof and the use thereof |
| 04/15/2008 | US7358372 more especially its tert-butylamine salt; synthesis intermediates; carried out in the presence of an activation reagent selected from N-methyl-N-phenyl-aminotriphenylphosphonium iodide and hexamethylphosphorus triamide together with ammonium perchlorate by Mitsunobu reaction |
| 04/15/2008 | US7358355 Antibodies against human parathyroid hormone related protein |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358353 Expose cells to gene and nucleotide sequence that encodes T or B cell epitope; generates antibodies that bind specifically; immunogenic |
| 04/15/2008 | US7358351 Endothelial cell expression patterns |
| 04/15/2008 | US7358348 β-catenin nuclear localized protein |
| 04/15/2008 | US7358342 Preparation derived from shark cartilage for treatment of diseased related to excessive PHF or excessive intracellular calcium |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358339 PRO polypeptide without the N-terminal signal sequence and/or the initiating methionine is encoded by a nucleotide sequence |
| 04/15/2008 | US7358338 Heme peptide |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358332 Bioactive peptides, uses thereof and process for the production of same |
| 04/15/2008 | US7358331 Truncated fragments of alpha-synuclein in Lewy body disease |
| 04/15/2008 | US7358330 oligopeptides derived from human chorionic gonadotropin (hCG); compositions exhibiting immunoregulatory activity as determined by measuring the compound's ability to modulate production of NO by a cell |
| 04/15/2008 | US7358329 Antagonists to chaperonin 10 |
| 04/15/2008 | US7358284 Particulate acellular tissue matrix |
| 04/15/2008 | US7358273 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, and degenerative diseases |
| 04/15/2008 | US7358254 Method for treating atherosclerosis employing an aP2 inhibitor and combination |
| 04/15/2008 | US7358237 Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2 |
| 04/15/2008 | US7358230 Comprises antiproliferative peptides and/or polypeptides for treating tumors |
| 04/15/2008 | US7358229 Deuterated cyclosporin analogs and their use as immunomodulating agents |
| 04/15/2008 | US7358228 Methods of treating pain using neurotrophic factors |
| 04/15/2008 | US7358227 Synergistic mixture of at least two recombinant bone morphogenetic protein monomers generated by contacting said the monomers with urea to prevent dimerization; slow release biodegradable glycolic acid-lactic acid copolymer |
| 04/15/2008 | US7358226 The localized, targeted delivery of a drug or contrast agent for imaging by administering and concentrating a carrier by exposing it to a radiation force generated by ultrasound waves at a frequency and pressure combination; rupturing;affecting tissue permeability or altering cell physiology |
| 04/15/2008 | US7358225 G-protein-coupled receptor proteins characterized by having sufficient binding affinity for corticotropin releasing factor(CRF) such that concentrations of # 10 nM of CRF occupy 350% of the binding sites of said receptor protein |
| 04/15/2008 | US7358088 And GD domains by determining if agent inhibits or augments heterodimerization of polypeptides; use in diagnosis of degenerative disorders (inflammatory conditions, cancer) |
| 04/15/2008 | US7358087 Adjuvant for enhancing immune response to preferential immunogen |
| 04/15/2008 | US7358076 Dehydroalanine-containing lantibiotic |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358068 For use as therapeutic agents in viral infections by human and animal viruses and in cancers caused by oncogene viruses; non-sequence complementary mode of action; drug screening |
| 04/15/2008 | US7358066 Variants and exons of the GlyT1 transporter |
| 04/15/2008 | US7358061 Methods of diagnosing thyroid carcinoma |
| 04/15/2008 | US7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease |
| 04/15/2008 | US7358044 Prophylactic and therapeutic benefits of a new class of immune stimulating peptides |
| 04/15/2008 | US7357934 Intracranial botulinum toxin therapy for focal epilepsy |
| 04/15/2008 | US7357932 Surface protein of Neisseria bacteria |
| 04/15/2008 | US7357928 Proteins for treatment of cancer by administering antinucleolin |
| 04/15/2008 | US7357927 Death domain containing receptors |
| 04/15/2008 | US7357925 Method for treating disorders and diseases treatable with human fibroblast interferon |
| 04/15/2008 | US7357924 Nucleic acids/proteins/antibodies/mimetics for cell differentiation/prolilferation control |
| 04/15/2008 | CA2454027C Residual solvent extraction method and microparticles produced thereby |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2405265C Method of preventing or treating diabetes |
| 04/15/2008 | CA2370201C Skin care compositions containing a combination of skin care actives |
| 04/15/2008 | CA2323239C Novel matrix metalloproteinase inhibitors and down-regulators |
| 04/15/2008 | CA2269655C Peptide compositions with growth factor-like activity |
| 04/15/2008 | CA2258740C Manufacturing process for the production of purified transferrin |
| 04/15/2008 | CA2250433C Human dnase ii |
| 04/15/2008 | CA2215800C Self-emulsifying formulation producing a positively charged emulsion |
| 04/15/2008 | CA2114859C Cytotoxic and antiviral compound |
| 04/15/2008 | CA2105888C Use of a direct thrombin inhibitor in the production of a drug presenting a thrombolytic activity |
| 04/10/2008 | WO2008043107A2 Use of tight junction antagonists to treat inflammatory bowel disease |
| 04/10/2008 | WO2008043102A2 Vasoactive intestinal polypeptide compositions |
| 04/10/2008 | WO2008043033A2 Fibrillation-resistant insulin and insulin analogues |
| 04/10/2008 | WO2008042970A2 Chitosan-coated calcium sulfate based medicament delivery system |
| 04/10/2008 | WO2008041909A1 A method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair |
| 04/10/2008 | WO2008041774A1 Sustained-release preparation having bone conduction ability |
| 04/10/2008 | WO2008041740A1 Glutathione preparation and method for production thereof |
| 04/10/2008 | WO2008041704A1 Controlled release preparation |
| 04/10/2008 | WO2008041219A1 A milk protein composition and use thereof |
| 04/10/2008 | WO2008041218A1 Antimicrobial and immunostimulatory system comprising an oxidoreductase enzyme |
| 04/10/2008 | WO2008041014A2 Interferon- alpha constructs for use in the treatment of diseases characterised by abnormal cell proliferation such as cancer |
| 04/10/2008 | WO2008040833A1 Method for obtaining bicyclic peptides |
| 04/10/2008 | WO2008040758A1 Peptides with high affinity for the prolactin receptor |
| 04/10/2008 | WO2008040557A1 A spinal nucleus pulposus implant |
| 04/10/2008 | WO2008040556A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 04/10/2008 | WO2008040469A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 04/10/2008 | WO2008040260A1 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
| 04/10/2008 | WO2008040230A1 Consolidant for trauma and ulcer comprising fibronectin |
| 04/10/2008 | WO2008040190A1 Small peptides for anti-angiogenesis and use thereof |
| 04/10/2008 | WO2008040111A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/10/2008 | WO2008040098A1 Immunogenic polypeptides derived from the cleavage loop of precursor hemagglutinin of an influenza virus |
| 04/10/2008 | WO2008040087A1 A method of treatment and agents useful for same |
| 04/10/2008 | WO2008040059A1 Anti-bacterially active agents and related methods |
| 04/10/2008 | WO2008022030A9 Promiscuous pap cd4 t cell epitopes |
| 04/10/2008 | WO2008020221A3 Topical application of fsh, lh, tsh or cg to the cervix |
| 04/10/2008 | WO2008015720A3 PEPTIDE DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 BINDING INTEGRIN α5β1, HAVING PROANGIOGENIC ACTIVITY |
| 04/10/2008 | WO2008012546A3 Azapeptides for use in therapy against interstitial cystitis |
| 04/10/2008 | WO2008011094A3 Cytokine induction of selectin ligands on cells |
| 04/10/2008 | WO2008007131A3 Treatment for demyelinating disease |
| 04/10/2008 | WO2008003780A3 Use of proteins of the sdf-1-family for improvement of axonal plasticity or for axonal regeneration following lesions |
| 04/10/2008 | WO2008003707A3 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
| 04/10/2008 | WO2007146689A3 Stabilized insulin-like growth factor polypeptides |
| 04/10/2008 | WO2007142986A3 Aminothiazole derivatives and their uses as antibacterial agents |
| 04/10/2008 | WO2007141344A3 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic |
| 04/10/2008 | WO2007141306A3 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist |